MK-3475 and Gemcitabine in Non-Small Cell Lung Cancer (NSCLC)

NCT02422381 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG: MK-3475
DRUG: Gemcitabine

Sponsor

Providence Health & Services

Collaborators

[object Object]
[object Object]